nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—ALB—ulcerative colitis	0.197	0.512	CbGaD
Enzalutamide—ABCB1—ulcerative colitis	0.188	0.488	CbGaD
Enzalutamide—CYP2B6—Nicotine—ulcerative colitis	0.0333	0.0647	CbGbCtD
Enzalutamide—CYP2B6—Cholecalciferol—ulcerative colitis	0.0299	0.058	CbGbCtD
Enzalutamide—CYP2C8—Nicotine—ulcerative colitis	0.0253	0.049	CbGbCtD
Enzalutamide—CYP3A4—Budesonide—ulcerative colitis	0.0235	0.0456	CbGbCtD
Enzalutamide—CYP2C8—Cholecalciferol—ulcerative colitis	0.0226	0.0439	CbGbCtD
Enzalutamide—CYP2C19—Nicotine—ulcerative colitis	0.0212	0.0411	CbGbCtD
Enzalutamide—CYP3A5—Sulfasalazine—ulcerative colitis	0.0204	0.0396	CbGbCtD
Enzalutamide—ALB—Prednisone—ulcerative colitis	0.0203	0.0394	CbGbCtD
Enzalutamide—CYP2C19—Cholecalciferol—ulcerative colitis	0.019	0.0369	CbGbCtD
Enzalutamide—CYP2C9—Nicotine—ulcerative colitis	0.0176	0.0342	CbGbCtD
Enzalutamide—ABCB1—Methylprednisolone—ulcerative colitis	0.0175	0.034	CbGbCtD
Enzalutamide—CYP3A5—Hydrocortisone—ulcerative colitis	0.0164	0.0318	CbGbCtD
Enzalutamide—CYP2D6—Nicotine—ulcerative colitis	0.0161	0.0312	CbGbCtD
Enzalutamide—CYP2C9—Cholecalciferol—ulcerative colitis	0.0158	0.0306	CbGbCtD
Enzalutamide—CYP2C8—Hydrocortisone—ulcerative colitis	0.0158	0.0306	CbGbCtD
Enzalutamide—CYP2D6—Cholecalciferol—ulcerative colitis	0.0144	0.028	CbGbCtD
Enzalutamide—CYP2C19—Prednisone—ulcerative colitis	0.0132	0.0255	CbGbCtD
Enzalutamide—CYP2B6—Dexamethasone—ulcerative colitis	0.0129	0.0251	CbGbCtD
Enzalutamide—ABCB1—Betamethasone—ulcerative colitis	0.0114	0.0221	CbGbCtD
Enzalutamide—ABCB1—Prednisolone—ulcerative colitis	0.0113	0.0218	CbGbCtD
Enzalutamide—ABCB1—Hydrocortisone—ulcerative colitis	0.0107	0.0207	CbGbCtD
Enzalutamide—ABCB1—Prednisone—ulcerative colitis	0.0106	0.0206	CbGbCtD
Enzalutamide—CYP3A4—Methylprednisolone—ulcerative colitis	0.0105	0.0204	CbGbCtD
Enzalutamide—CYP3A4—Nicotine—ulcerative colitis	0.0102	0.0199	CbGbCtD
Enzalutamide—CYP3A5—Dexamethasone—ulcerative colitis	0.0102	0.0198	CbGbCtD
Enzalutamide—CYP2C8—Dexamethasone—ulcerative colitis	0.0098	0.019	CbGbCtD
Enzalutamide—CYP3A4—Cholecalciferol—ulcerative colitis	0.00919	0.0178	CbGbCtD
Enzalutamide—CYP2C19—Dexamethasone—ulcerative colitis	0.00822	0.0159	CbGbCtD
Enzalutamide—CYP3A4—Triamcinolone—ulcerative colitis	0.00796	0.0154	CbGbCtD
Enzalutamide—CYP2C9—Dexamethasone—ulcerative colitis	0.00684	0.0133	CbGbCtD
Enzalutamide—CYP3A4—Betamethasone—ulcerative colitis	0.00683	0.0133	CbGbCtD
Enzalutamide—CYP3A4—Prednisolone—ulcerative colitis	0.00674	0.0131	CbGbCtD
Enzalutamide—ABCB1—Dexamethasone—ulcerative colitis	0.00663	0.0129	CbGbCtD
Enzalutamide—CYP3A4—Hydrocortisone—ulcerative colitis	0.00639	0.0124	CbGbCtD
Enzalutamide—CYP3A4—Prednisone—ulcerative colitis	0.00637	0.0124	CbGbCtD
Enzalutamide—CYP2D6—Dexamethasone—ulcerative colitis	0.00625	0.0121	CbGbCtD
Enzalutamide—CYP3A4—Dexamethasone—ulcerative colitis	0.00397	0.00771	CbGbCtD
Enzalutamide—Epistaxis—Budesonide—ulcerative colitis	0.000447	0.00464	CcSEcCtD
Enzalutamide—Sinusitis—Budesonide—ulcerative colitis	0.000445	0.00462	CcSEcCtD
Enzalutamide—Thrombocytopenia—Mercaptopurine—ulcerative colitis	0.000444	0.0046	CcSEcCtD
Enzalutamide—Skin disorder—Mercaptopurine—ulcerative colitis	0.00044	0.00457	CcSEcCtD
Enzalutamide—Nervous system disorder—Nicotine—ulcerative colitis	0.000431	0.00447	CcSEcCtD
Enzalutamide—Rhinitis—Budesonide—ulcerative colitis	0.000427	0.00443	CcSEcCtD
Enzalutamide—Pneumonia—Azathioprine—ulcerative colitis	0.000426	0.00442	CcSEcCtD
Enzalutamide—Infestation—Azathioprine—ulcerative colitis	0.000423	0.00439	CcSEcCtD
Enzalutamide—Infestation NOS—Azathioprine—ulcerative colitis	0.000423	0.00439	CcSEcCtD
Enzalutamide—Pharyngitis—Budesonide—ulcerative colitis	0.000423	0.00438	CcSEcCtD
Enzalutamide—Urinary tract disorder—Budesonide—ulcerative colitis	0.00042	0.00436	CcSEcCtD
Enzalutamide—Oedema peripheral—Budesonide—ulcerative colitis	0.000419	0.00435	CcSEcCtD
Enzalutamide—Connective tissue disorder—Budesonide—ulcerative colitis	0.000418	0.00434	CcSEcCtD
Enzalutamide—Urethral disorder—Budesonide—ulcerative colitis	0.000417	0.00433	CcSEcCtD
Enzalutamide—Bronchitis—Mesalazine—ulcerative colitis	0.000416	0.00432	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Mercaptopurine—ulcerative colitis	0.000413	0.00428	CcSEcCtD
Enzalutamide—Neutropenia—Mesalazine—ulcerative colitis	0.000404	0.0042	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Mesalazine—ulcerative colitis	0.000402	0.00417	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Nicotine—ulcerative colitis	0.0004	0.00415	CcSEcCtD
Enzalutamide—Pollakiuria—Mesalazine—ulcerative colitis	0.0004	0.00415	CcSEcCtD
Enzalutamide—Insomnia—Nicotine—ulcerative colitis	0.000397	0.00412	CcSEcCtD
Enzalutamide—Injury—Prednisolone—ulcerative colitis	0.000396	0.00411	CcSEcCtD
Enzalutamide—Paraesthesia—Nicotine—ulcerative colitis	0.000394	0.00409	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.000391	0.00406	CcSEcCtD
Enzalutamide—Pneumonia—Mesalazine—ulcerative colitis	0.000388	0.00402	CcSEcCtD
Enzalutamide—Injury—Hydrocortisone—ulcerative colitis	0.000387	0.00402	CcSEcCtD
Enzalutamide—Angiopathy—Budesonide—ulcerative colitis	0.000386	0.00401	CcSEcCtD
Enzalutamide—Infestation NOS—Mesalazine—ulcerative colitis	0.000386	0.004	CcSEcCtD
Enzalutamide—Infestation—Mesalazine—ulcerative colitis	0.000386	0.004	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.000379	0.00393	CcSEcCtD
Enzalutamide—Fatigue—Nicotine—ulcerative colitis	0.000379	0.00393	CcSEcCtD
Enzalutamide—Mental disorder—Budesonide—ulcerative colitis	0.000373	0.00387	CcSEcCtD
Enzalutamide—Haematuria—Mesalazine—ulcerative colitis	0.000368	0.00381	CcSEcCtD
Enzalutamide—Injury—Triamcinolone—ulcerative colitis	0.000365	0.00378	CcSEcCtD
Enzalutamide—Epistaxis—Mesalazine—ulcerative colitis	0.000364	0.00377	CcSEcCtD
Enzalutamide—Injury—Methylprednisolone—ulcerative colitis	0.000364	0.00377	CcSEcCtD
Enzalutamide—Sinusitis—Mesalazine—ulcerative colitis	0.000362	0.00375	CcSEcCtD
Enzalutamide—Back pain—Budesonide—ulcerative colitis	0.000358	0.00372	CcSEcCtD
Enzalutamide—Amnesia—Methylprednisolone—ulcerative colitis	0.000356	0.00369	CcSEcCtD
Enzalutamide—Rhinitis—Mesalazine—ulcerative colitis	0.000347	0.0036	CcSEcCtD
Enzalutamide—Pharyngitis—Mesalazine—ulcerative colitis	0.000344	0.00356	CcSEcCtD
Enzalutamide—Urinary tract disorder—Mesalazine—ulcerative colitis	0.000342	0.00355	CcSEcCtD
Enzalutamide—Oedema peripheral—Mesalazine—ulcerative colitis	0.000341	0.00354	CcSEcCtD
Enzalutamide—Connective tissue disorder—Mesalazine—ulcerative colitis	0.00034	0.00353	CcSEcCtD
Enzalutamide—Urethral disorder—Mesalazine—ulcerative colitis	0.000339	0.00352	CcSEcCtD
Enzalutamide—Dry skin—Prednisolone—ulcerative colitis	0.000334	0.00346	CcSEcCtD
Enzalutamide—Vertigo—Budesonide—ulcerative colitis	0.000333	0.00345	CcSEcCtD
Enzalutamide—Injury—Dexamethasone—ulcerative colitis	0.000331	0.00343	CcSEcCtD
Enzalutamide—Injury—Betamethasone—ulcerative colitis	0.000331	0.00343	CcSEcCtD
Enzalutamide—Dry skin—Hydrocortisone—ulcerative colitis	0.000326	0.00338	CcSEcCtD
Enzalutamide—Muscular weakness—Prednisolone—ulcerative colitis	0.000321	0.00333	CcSEcCtD
Enzalutamide—Hypertension—Budesonide—ulcerative colitis	0.00032	0.00332	CcSEcCtD
Enzalutamide—Sepsis—Prednisone—ulcerative colitis	0.000317	0.00328	CcSEcCtD
Enzalutamide—Arthralgia—Budesonide—ulcerative colitis	0.000316	0.00327	CcSEcCtD
Enzalutamide—Asthenia—Nicotine—ulcerative colitis	0.000315	0.00327	CcSEcCtD
Enzalutamide—Anxiety—Budesonide—ulcerative colitis	0.000314	0.00326	CcSEcCtD
Enzalutamide—Angiopathy—Mesalazine—ulcerative colitis	0.000314	0.00326	CcSEcCtD
Enzalutamide—Muscular weakness—Hydrocortisone—ulcerative colitis	0.000314	0.00326	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.000313	0.00325	CcSEcCtD
Enzalutamide—Pruritus—Nicotine—ulcerative colitis	0.000311	0.00322	CcSEcCtD
Enzalutamide—Diarrhoea—Mercaptopurine—ulcerative colitis	0.00031	0.00322	CcSEcCtD
Enzalutamide—Mental disorder—Mesalazine—ulcerative colitis	0.000303	0.00315	CcSEcCtD
Enzalutamide—Diarrhoea—Nicotine—ulcerative colitis	0.0003	0.00312	CcSEcCtD
Enzalutamide—Infection—Budesonide—ulcerative colitis	0.0003	0.00312	CcSEcCtD
Enzalutamide—Nervous system disorder—Budesonide—ulcerative colitis	0.000297	0.00308	CcSEcCtD
Enzalutamide—Leukopenia—Azathioprine—ulcerative colitis	0.000296	0.00307	CcSEcCtD
Enzalutamide—Muscular weakness—Triamcinolone—ulcerative colitis	0.000296	0.00307	CcSEcCtD
Enzalutamide—Muscular weakness—Methylprednisolone—ulcerative colitis	0.000295	0.00306	CcSEcCtD
Enzalutamide—Skin disorder—Budesonide—ulcerative colitis	0.000294	0.00305	CcSEcCtD
Enzalutamide—Back pain—Mesalazine—ulcerative colitis	0.000292	0.00302	CcSEcCtD
Enzalutamide—Dizziness—Nicotine—ulcerative colitis	0.00029	0.00301	CcSEcCtD
Enzalutamide—Injury—Prednisone—ulcerative colitis	0.000288	0.00299	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Hydrocortisone—ulcerative colitis	0.000286	0.00297	CcSEcCtD
Enzalutamide—Amnesia—Prednisone—ulcerative colitis	0.000282	0.00292	CcSEcCtD
Enzalutamide—Arthralgia—Azathioprine—ulcerative colitis	0.000282	0.00292	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.00028	0.0029	CcSEcCtD
Enzalutamide—Dry skin—Betamethasone—ulcerative colitis	0.000279	0.00289	CcSEcCtD
Enzalutamide—Dry skin—Dexamethasone—ulcerative colitis	0.000279	0.00289	CcSEcCtD
Enzalutamide—Bronchitis—Triamcinolone—ulcerative colitis	0.000279	0.00289	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Budesonide—ulcerative colitis	0.000276	0.00286	CcSEcCtD
Enzalutamide—Headache—Nicotine—ulcerative colitis	0.000275	0.00285	CcSEcCtD
Enzalutamide—Infestation NOS—Hydrocortisone—ulcerative colitis	0.000274	0.00285	CcSEcCtD
Enzalutamide—Infestation—Hydrocortisone—ulcerative colitis	0.000274	0.00285	CcSEcCtD
Enzalutamide—Insomnia—Budesonide—ulcerative colitis	0.000274	0.00284	CcSEcCtD
Enzalutamide—Paraesthesia—Budesonide—ulcerative colitis	0.000272	0.00282	CcSEcCtD
Enzalutamide—Vertigo—Mesalazine—ulcerative colitis	0.000271	0.00281	CcSEcCtD
Enzalutamide—Leukopenia—Mesalazine—ulcerative colitis	0.00027	0.0028	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Triamcinolone—ulcerative colitis	0.000269	0.00279	CcSEcCtD
Enzalutamide—Infection—Azathioprine—ulcerative colitis	0.000268	0.00278	CcSEcCtD
Enzalutamide—Muscular weakness—Dexamethasone—ulcerative colitis	0.000268	0.00278	CcSEcCtD
Enzalutamide—Muscular weakness—Betamethasone—ulcerative colitis	0.000268	0.00278	CcSEcCtD
Enzalutamide—Thrombocytopenia—Azathioprine—ulcerative colitis	0.000264	0.00274	CcSEcCtD
Enzalutamide—Skin disorder—Azathioprine—ulcerative colitis	0.000262	0.00272	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000261	0.00271	CcSEcCtD
Enzalutamide—Fatigue—Budesonide—ulcerative colitis	0.000261	0.00271	CcSEcCtD
Enzalutamide—Hypertension—Mesalazine—ulcerative colitis	0.00026	0.0027	CcSEcCtD
Enzalutamide—Infestation NOS—Methylprednisolone—ulcerative colitis	0.000258	0.00267	CcSEcCtD
Enzalutamide—Infestation—Methylprednisolone—ulcerative colitis	0.000258	0.00267	CcSEcCtD
Enzalutamide—Arthralgia—Mesalazine—ulcerative colitis	0.000257	0.00266	CcSEcCtD
Enzalutamide—Anxiety—Mesalazine—ulcerative colitis	0.000256	0.00265	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000255	0.00264	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Azathioprine—ulcerative colitis	0.000246	0.00255	CcSEcCtD
Enzalutamide—Infection—Mesalazine—ulcerative colitis	0.000244	0.00254	CcSEcCtD
Enzalutamide—Epistaxis—Triamcinolone—ulcerative colitis	0.000244	0.00253	CcSEcCtD
Enzalutamide—Dry skin—Prednisone—ulcerative colitis	0.000243	0.00252	CcSEcCtD
Enzalutamide—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.000242	0.00251	CcSEcCtD
Enzalutamide—Nervous system disorder—Mesalazine—ulcerative colitis	0.000241	0.0025	CcSEcCtD
Enzalutamide—Thrombocytopenia—Mesalazine—ulcerative colitis	0.000241	0.0025	CcSEcCtD
Enzalutamide—Skin disorder—Mesalazine—ulcerative colitis	0.000239	0.00248	CcSEcCtD
Enzalutamide—Muscular weakness—Prednisone—ulcerative colitis	0.000234	0.00242	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000233	0.00242	CcSEcCtD
Enzalutamide—Rhinitis—Triamcinolone—ulcerative colitis	0.000232	0.00241	CcSEcCtD
Enzalutamide—Rhinitis—Methylprednisolone—ulcerative colitis	0.000232	0.00241	CcSEcCtD
Enzalutamide—Pharyngitis—Triamcinolone—ulcerative colitis	0.00023	0.00239	CcSEcCtD
Enzalutamide—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000227	0.00236	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000224	0.00232	CcSEcCtD
Enzalutamide—Insomnia—Mesalazine—ulcerative colitis	0.000222	0.00231	CcSEcCtD
Enzalutamide—Paraesthesia—Mesalazine—ulcerative colitis	0.000221	0.00229	CcSEcCtD
Enzalutamide—Asthenia—Budesonide—ulcerative colitis	0.000217	0.00225	CcSEcCtD
Enzalutamide—Mental disorder—Hydrocortisone—ulcerative colitis	0.000216	0.00224	CcSEcCtD
Enzalutamide—Neutropenia—Prednisone—ulcerative colitis	0.000214	0.00222	CcSEcCtD
Enzalutamide—Pruritus—Budesonide—ulcerative colitis	0.000214	0.00222	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000212	0.0022	CcSEcCtD
Enzalutamide—Fatigue—Mesalazine—ulcerative colitis	0.000212	0.0022	CcSEcCtD
Enzalutamide—Angiopathy—Methylprednisolone—ulcerative colitis	0.00021	0.00218	CcSEcCtD
Enzalutamide—Diarrhoea—Budesonide—ulcerative colitis	0.000207	0.00215	CcSEcCtD
Enzalutamide—Mental disorder—Methylprednisolone—ulcerative colitis	0.000203	0.0021	CcSEcCtD
Enzalutamide—Dizziness—Budesonide—ulcerative colitis	0.0002	0.00207	CcSEcCtD
Enzalutamide—Vertigo—Prednisolone—ulcerative colitis	0.000197	0.00205	CcSEcCtD
Enzalutamide—Back pain—Triamcinolone—ulcerative colitis	0.000195	0.00203	CcSEcCtD
Enzalutamide—Vertigo—Hydrocortisone—ulcerative colitis	0.000193	0.002	CcSEcCtD
Enzalutamide—Angiopathy—Dexamethasone—ulcerative colitis	0.000191	0.00198	CcSEcCtD
Enzalutamide—Angiopathy—Betamethasone—ulcerative colitis	0.000191	0.00198	CcSEcCtD
Enzalutamide—Convulsion—Prednisolone—ulcerative colitis	0.00019	0.00197	CcSEcCtD
Enzalutamide—Headache—Budesonide—ulcerative colitis	0.000189	0.00197	CcSEcCtD
Enzalutamide—Hypertension—Prednisolone—ulcerative colitis	0.000189	0.00197	CcSEcCtD
Enzalutamide—Convulsion—Hydrocortisone—ulcerative colitis	0.000186	0.00193	CcSEcCtD
Enzalutamide—Hypertension—Hydrocortisone—ulcerative colitis	0.000185	0.00192	CcSEcCtD
Enzalutamide—Diarrhoea—Azathioprine—ulcerative colitis	0.000185	0.00192	CcSEcCtD
Enzalutamide—Anxiety—Hydrocortisone—ulcerative colitis	0.000182	0.00189	CcSEcCtD
Enzalutamide—Vertigo—Triamcinolone—ulcerative colitis	0.000181	0.00188	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000181	0.00188	CcSEcCtD
Enzalutamide—Vertigo—Methylprednisolone—ulcerative colitis	0.000181	0.00188	CcSEcCtD
Enzalutamide—Connective tissue disorder—Prednisone—ulcerative colitis	0.00018	0.00187	CcSEcCtD
Enzalutamide—Dizziness—Azathioprine—ulcerative colitis	0.000179	0.00185	CcSEcCtD
Enzalutamide—Asthenia—Mesalazine—ulcerative colitis	0.000176	0.00183	CcSEcCtD
Enzalutamide—Convulsion—Triamcinolone—ulcerative colitis	0.000175	0.00181	CcSEcCtD
Enzalutamide—Convulsion—Methylprednisolone—ulcerative colitis	0.000174	0.00181	CcSEcCtD
Enzalutamide—Hypertension—Triamcinolone—ulcerative colitis	0.000174	0.00181	CcSEcCtD
Enzalutamide—Pruritus—Mesalazine—ulcerative colitis	0.000174	0.00181	CcSEcCtD
Enzalutamide—Hypertension—Methylprednisolone—ulcerative colitis	0.000174	0.0018	CcSEcCtD
Enzalutamide—Infection—Hydrocortisone—ulcerative colitis	0.000174	0.0018	CcSEcCtD
Enzalutamide—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000172	0.00178	CcSEcCtD
Enzalutamide—Arthralgia—Methylprednisolone—ulcerative colitis	0.000171	0.00178	CcSEcCtD
Enzalutamide—Anxiety—Methylprednisolone—ulcerative colitis	0.000171	0.00177	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.00017	0.00177	CcSEcCtD
Enzalutamide—Skin disorder—Hydrocortisone—ulcerative colitis	0.00017	0.00176	CcSEcCtD
Enzalutamide—Headache—Azathioprine—ulcerative colitis	0.000169	0.00175	CcSEcCtD
Enzalutamide—Diarrhoea—Mesalazine—ulcerative colitis	0.000168	0.00175	CcSEcCtD
Enzalutamide—Angiopathy—Prednisone—ulcerative colitis	0.000166	0.00172	CcSEcCtD
Enzalutamide—Vertigo—Dexamethasone—ulcerative colitis	0.000165	0.00171	CcSEcCtD
Enzalutamide—Vertigo—Betamethasone—ulcerative colitis	0.000165	0.00171	CcSEcCtD
Enzalutamide—Infection—Triamcinolone—ulcerative colitis	0.000164	0.0017	CcSEcCtD
Enzalutamide—Infection—Methylprednisolone—ulcerative colitis	0.000163	0.00169	CcSEcCtD
Enzalutamide—Dizziness—Mesalazine—ulcerative colitis	0.000163	0.00169	CcSEcCtD
Enzalutamide—Insomnia—Prednisolone—ulcerative colitis	0.000162	0.00168	CcSEcCtD
Enzalutamide—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000161	0.00167	CcSEcCtD
Enzalutamide—Paraesthesia—Prednisolone—ulcerative colitis	0.000161	0.00167	CcSEcCtD
Enzalutamide—Mental disorder—Prednisone—ulcerative colitis	0.00016	0.00166	CcSEcCtD
Enzalutamide—Skin disorder—Methylprednisolone—ulcerative colitis	0.00016	0.00166	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000159	0.00165	CcSEcCtD
Enzalutamide—Convulsion—Dexamethasone—ulcerative colitis	0.000159	0.00165	CcSEcCtD
Enzalutamide—Convulsion—Betamethasone—ulcerative colitis	0.000159	0.00165	CcSEcCtD
Enzalutamide—Insomnia—Hydrocortisone—ulcerative colitis	0.000158	0.00164	CcSEcCtD
Enzalutamide—Hypertension—Betamethasone—ulcerative colitis	0.000158	0.00164	CcSEcCtD
Enzalutamide—Hypertension—Dexamethasone—ulcerative colitis	0.000158	0.00164	CcSEcCtD
Enzalutamide—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000157	0.00163	CcSEcCtD
Enzalutamide—Anxiety—Betamethasone—ulcerative colitis	0.000155	0.00161	CcSEcCtD
Enzalutamide—Anxiety—Dexamethasone—ulcerative colitis	0.000155	0.00161	CcSEcCtD
Enzalutamide—Headache—Mesalazine—ulcerative colitis	0.000154	0.0016	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000151	0.00157	CcSEcCtD
Enzalutamide—Fatigue—Hydrocortisone—ulcerative colitis	0.000151	0.00156	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.00015	0.00156	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.00015	0.00155	CcSEcCtD
Enzalutamide—Insomnia—Triamcinolone—ulcerative colitis	0.000149	0.00155	CcSEcCtD
Enzalutamide—Insomnia—Methylprednisolone—ulcerative colitis	0.000149	0.00154	CcSEcCtD
Enzalutamide—Infection—Dexamethasone—ulcerative colitis	0.000148	0.00154	CcSEcCtD
Enzalutamide—Infection—Betamethasone—ulcerative colitis	0.000148	0.00154	CcSEcCtD
Enzalutamide—Paraesthesia—Triamcinolone—ulcerative colitis	0.000148	0.00153	CcSEcCtD
Enzalutamide—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000148	0.00153	CcSEcCtD
Enzalutamide—Nervous system disorder—Betamethasone—ulcerative colitis	0.000147	0.00152	CcSEcCtD
Enzalutamide—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000147	0.00152	CcSEcCtD
Enzalutamide—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000146	0.00152	CcSEcCtD
Enzalutamide—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000146	0.00152	CcSEcCtD
Enzalutamide—Vertigo—Prednisone—ulcerative colitis	0.000143	0.00149	CcSEcCtD
Enzalutamide—Fatigue—Triamcinolone—ulcerative colitis	0.000142	0.00147	CcSEcCtD
Enzalutamide—Fatigue—Methylprednisolone—ulcerative colitis	0.000142	0.00147	CcSEcCtD
Enzalutamide—Convulsion—Prednisone—ulcerative colitis	0.000138	0.00143	CcSEcCtD
Enzalutamide—Hypertension—Prednisone—ulcerative colitis	0.000138	0.00143	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000136	0.00141	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000136	0.00141	CcSEcCtD
Enzalutamide—Arthralgia—Prednisone—ulcerative colitis	0.000136	0.00141	CcSEcCtD
Enzalutamide—Anxiety—Prednisone—ulcerative colitis	0.000135	0.0014	CcSEcCtD
Enzalutamide—Insomnia—Dexamethasone—ulcerative colitis	0.000135	0.0014	CcSEcCtD
Enzalutamide—Insomnia—Betamethasone—ulcerative colitis	0.000135	0.0014	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000135	0.0014	CcSEcCtD
Enzalutamide—Paraesthesia—Betamethasone—ulcerative colitis	0.000134	0.00139	CcSEcCtD
Enzalutamide—Paraesthesia—Dexamethasone—ulcerative colitis	0.000134	0.00139	CcSEcCtD
Enzalutamide—Infection—Prednisone—ulcerative colitis	0.000129	0.00134	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000129	0.00134	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000129	0.00134	CcSEcCtD
Enzalutamide—Fatigue—Dexamethasone—ulcerative colitis	0.000129	0.00134	CcSEcCtD
Enzalutamide—Fatigue—Betamethasone—ulcerative colitis	0.000129	0.00134	CcSEcCtD
Enzalutamide—Nervous system disorder—Prednisone—ulcerative colitis	0.000128	0.00132	CcSEcCtD
Enzalutamide—Skin disorder—Prednisone—ulcerative colitis	0.000126	0.00131	CcSEcCtD
Enzalutamide—Asthenia—Hydrocortisone—ulcerative colitis	0.000125	0.0013	CcSEcCtD
Enzalutamide—Pruritus—Hydrocortisone—ulcerative colitis	0.000124	0.00128	CcSEcCtD
Enzalutamide—Diarrhoea—Hydrocortisone—ulcerative colitis	0.00012	0.00124	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000119	0.00123	CcSEcCtD
Enzalutamide—Dizziness—Prednisolone—ulcerative colitis	0.000118	0.00123	CcSEcCtD
Enzalutamide—Asthenia—Triamcinolone—ulcerative colitis	0.000118	0.00123	CcSEcCtD
Enzalutamide—Asthenia—Methylprednisolone—ulcerative colitis	0.000118	0.00122	CcSEcCtD
Enzalutamide—Insomnia—Prednisone—ulcerative colitis	0.000118	0.00122	CcSEcCtD
Enzalutamide—Paraesthesia—Prednisone—ulcerative colitis	0.000117	0.00121	CcSEcCtD
Enzalutamide—Pruritus—Triamcinolone—ulcerative colitis	0.000117	0.00121	CcSEcCtD
Enzalutamide—Pruritus—Methylprednisolone—ulcerative colitis	0.000116	0.00121	CcSEcCtD
Enzalutamide—Dizziness—Hydrocortisone—ulcerative colitis	0.000116	0.0012	CcSEcCtD
Enzalutamide—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000112	0.00117	CcSEcCtD
Enzalutamide—Fatigue—Prednisone—ulcerative colitis	0.000112	0.00116	CcSEcCtD
Enzalutamide—Headache—Prednisolone—ulcerative colitis	0.000112	0.00116	CcSEcCtD
Enzalutamide—Headache—Hydrocortisone—ulcerative colitis	0.00011	0.00114	CcSEcCtD
Enzalutamide—Dizziness—Triamcinolone—ulcerative colitis	0.000109	0.00113	CcSEcCtD
Enzalutamide—Dizziness—Methylprednisolone—ulcerative colitis	0.000109	0.00113	CcSEcCtD
Enzalutamide—Asthenia—Dexamethasone—ulcerative colitis	0.000107	0.00111	CcSEcCtD
Enzalutamide—Asthenia—Betamethasone—ulcerative colitis	0.000107	0.00111	CcSEcCtD
Enzalutamide—Pruritus—Betamethasone—ulcerative colitis	0.000106	0.0011	CcSEcCtD
Enzalutamide—Pruritus—Dexamethasone—ulcerative colitis	0.000106	0.0011	CcSEcCtD
Enzalutamide—Headache—Triamcinolone—ulcerative colitis	0.000103	0.00107	CcSEcCtD
Enzalutamide—Headache—Methylprednisolone—ulcerative colitis	0.000103	0.00107	CcSEcCtD
Enzalutamide—Diarrhoea—Dexamethasone—ulcerative colitis	0.000102	0.00106	CcSEcCtD
Enzalutamide—Diarrhoea—Betamethasone—ulcerative colitis	0.000102	0.00106	CcSEcCtD
Enzalutamide—Dizziness—Dexamethasone—ulcerative colitis	9.88e-05	0.00103	CcSEcCtD
Enzalutamide—Dizziness—Betamethasone—ulcerative colitis	9.88e-05	0.00103	CcSEcCtD
Enzalutamide—Headache—Betamethasone—ulcerative colitis	9.36e-05	0.000971	CcSEcCtD
Enzalutamide—Headache—Dexamethasone—ulcerative colitis	9.36e-05	0.000971	CcSEcCtD
Enzalutamide—Asthenia—Prednisone—ulcerative colitis	9.34e-05	0.000969	CcSEcCtD
Enzalutamide—Pruritus—Prednisone—ulcerative colitis	9.21e-05	0.000955	CcSEcCtD
Enzalutamide—Diarrhoea—Prednisone—ulcerative colitis	8.9e-05	0.000924	CcSEcCtD
Enzalutamide—Dizziness—Prednisone—ulcerative colitis	8.61e-05	0.000893	CcSEcCtD
Enzalutamide—Headache—Prednisone—ulcerative colitis	8.15e-05	0.000846	CcSEcCtD
Enzalutamide—AR—Regulation of nuclear SMAD2/3 signaling—IL10—ulcerative colitis	2.01e-05	0.00789	CbGpPWpGaD
Enzalutamide—AR—Notch-mediated HES/HEY network—JAK2—ulcerative colitis	1.86e-05	0.00731	CbGpPWpGaD
Enzalutamide—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	1.82e-05	0.00713	CbGpPWpGaD
Enzalutamide—CYP2C19—Arachidonic acid metabolism—PTGS1—ulcerative colitis	1.81e-05	0.00713	CbGpPWpGaD
Enzalutamide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	1.81e-05	0.00712	CbGpPWpGaD
Enzalutamide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	1.81e-05	0.0071	CbGpPWpGaD
Enzalutamide—ALB—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	1.79e-05	0.00704	CbGpPWpGaD
Enzalutamide—AR—Notch-mediated HES/HEY network—CD4—ulcerative colitis	1.76e-05	0.00693	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—MPO—ulcerative colitis	1.76e-05	0.00691	CbGpPWpGaD
Enzalutamide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	1.68e-05	0.00662	CbGpPWpGaD
Enzalutamide—CYP2B6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	1.68e-05	0.00661	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	1.67e-05	0.00656	CbGpPWpGaD
Enzalutamide—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	1.66e-05	0.00651	CbGpPWpGaD
Enzalutamide—CYP2C9—Arachidonic acid metabolism—PTGS1—ulcerative colitis	1.65e-05	0.0065	CbGpPWpGaD
Enzalutamide—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	1.64e-05	0.00646	CbGpPWpGaD
Enzalutamide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	1.59e-05	0.00626	CbGpPWpGaD
Enzalutamide—ABCB1—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	1.59e-05	0.00625	CbGpPWpGaD
Enzalutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	1.58e-05	0.0062	CbGpPWpGaD
Enzalutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	1.57e-05	0.00618	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—ZFP90—ulcerative colitis	1.56e-05	0.00611	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—NR5A2—ulcerative colitis	1.48e-05	0.00583	CbGpPWpGaD
Enzalutamide—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	1.42e-05	0.0056	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—MPO—ulcerative colitis	1.4e-05	0.00549	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—ulcerative colitis	1.39e-05	0.00545	CbGpPWpGaD
Enzalutamide—AR—Notch-mediated HES/HEY network—STAT3—ulcerative colitis	1.36e-05	0.00536	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	1.29e-05	0.00509	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—PTGS1—ulcerative colitis	1.29e-05	0.00505	CbGpPWpGaD
Enzalutamide—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	1.27e-05	0.005	CbGpPWpGaD
Enzalutamide—ALB—Platelet degranulation—CALM3—ulcerative colitis	1.25e-05	0.00491	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	1.23e-05	0.00483	CbGpPWpGaD
Enzalutamide—ALB—Response to elevated platelet cytosolic Ca2+—CALM3—ulcerative colitis	1.19e-05	0.00468	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—IL10—ulcerative colitis	1.19e-05	0.00467	CbGpPWpGaD
Enzalutamide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	1.17e-05	0.00462	CbGpPWpGaD
Enzalutamide—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	1.17e-05	0.00459	CbGpPWpGaD
Enzalutamide—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	1.16e-05	0.00455	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	1.14e-05	0.00449	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—CRP—ulcerative colitis	1.14e-05	0.00447	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—ulcerative colitis	1.11e-05	0.00436	CbGpPWpGaD
Enzalutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	1.1e-05	0.00431	CbGpPWpGaD
Enzalutamide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	1.09e-05	0.00429	CbGpPWpGaD
Enzalutamide—AR—Androgen receptor signaling pathway—RELA—ulcerative colitis	1.08e-05	0.00425	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	1.07e-05	0.00422	CbGpPWpGaD
Enzalutamide—ALB—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	1.06e-05	0.00415	CbGpPWpGaD
Enzalutamide—ALB—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	1.06e-05	0.00415	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PROCR—ulcerative colitis	1.05e-05	0.00413	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—ICAM1—ulcerative colitis	1.04e-05	0.00411	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	1.04e-05	0.00409	CbGpPWpGaD
Enzalutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	1.04e-05	0.00409	CbGpPWpGaD
Enzalutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	1.04e-05	0.00408	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—MMP1—ulcerative colitis	1.04e-05	0.00408	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—ulcerative colitis	1e-05	0.00394	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	9.45e-06	0.00371	CbGpPWpGaD
Enzalutamide—CYP2C19—Melatonin metabolism and effects—NFKB1—ulcerative colitis	9.33e-06	0.00367	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—CRP—ulcerative colitis	9.25e-06	0.00363	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	9.1e-06	0.00358	CbGpPWpGaD
Enzalutamide—CYP2B6—Biological oxidations—PTGS1—ulcerative colitis	8.93e-06	0.00351	CbGpPWpGaD
Enzalutamide—CYP3A5—Biological oxidations—PTGS1—ulcerative colitis	8.73e-06	0.00343	CbGpPWpGaD
Enzalutamide—CYP2D6—Melatonin metabolism and effects—NFKB1—ulcerative colitis	8.58e-06	0.00337	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—ICAM1—ulcerative colitis	8.5e-06	0.00334	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—IL10—ulcerative colitis	8.35e-06	0.00328	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—CDH1—ulcerative colitis	8.34e-06	0.00328	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—HNF4A—ulcerative colitis	8.29e-06	0.00326	CbGpPWpGaD
Enzalutamide—AR—Androgen receptor signaling pathway—STAT3—ulcerative colitis	8.19e-06	0.00322	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—MAML2—ulcerative colitis	8.08e-06	0.00317	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	7.98e-06	0.00313	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—GNA12—ulcerative colitis	7.96e-06	0.00313	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—IFNG—ulcerative colitis	7.95e-06	0.00312	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—RELA—ulcerative colitis	7.84e-06	0.00308	CbGpPWpGaD
Enzalutamide—CYP2C8—Arachidonic acid metabolism—PTGS2—ulcerative colitis	7.79e-06	0.00306	CbGpPWpGaD
Enzalutamide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	7.64e-06	0.003	CbGpPWpGaD
Enzalutamide—CYP2C8—Biological oxidations—PTGS1—ulcerative colitis	7.56e-06	0.00297	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—CRP—ulcerative colitis	7.35e-06	0.00289	CbGpPWpGaD
Enzalutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	7.23e-06	0.00284	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—NR5A2—ulcerative colitis	7.14e-06	0.00281	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—IL1B—ulcerative colitis	7.09e-06	0.00279	CbGpPWpGaD
Enzalutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—ulcerative colitis	6.95e-06	0.00273	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	6.8e-06	0.00267	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—ICAM1—ulcerative colitis	6.75e-06	0.00265	CbGpPWpGaD
Enzalutamide—CYP2C19—Biological oxidations—PTGS1—ulcerative colitis	6.75e-06	0.00265	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	6.72e-06	0.00264	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—NFKB1—ulcerative colitis	6.62e-06	0.0026	CbGpPWpGaD
Enzalutamide—ALB—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	6.57e-06	0.00258	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	6.5e-06	0.00255	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—IFNG—ulcerative colitis	6.47e-06	0.00254	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—RELA—ulcerative colitis	6.38e-06	0.00251	CbGpPWpGaD
Enzalutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	6.34e-06	0.00249	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	6.23e-06	0.00245	CbGpPWpGaD
Enzalutamide—CYP2D6—Biological oxidations—PTGS1—ulcerative colitis	6.21e-06	0.00244	CbGpPWpGaD
Enzalutamide—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	6.16e-06	0.00242	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—NFKB1—ulcerative colitis	5.97e-06	0.00235	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	5.81e-06	0.00229	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—IL1B—ulcerative colitis	5.77e-06	0.00227	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—IL2—ulcerative colitis	5.75e-06	0.00226	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	5.7e-06	0.00224	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—CALM3—ulcerative colitis	5.54e-06	0.00218	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—NFKB1—ulcerative colitis	5.38e-06	0.00212	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	5.36e-06	0.00211	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	5.36e-06	0.00211	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—VDR—ulcerative colitis	5.16e-06	0.00203	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—TNF—ulcerative colitis	5.15e-06	0.00202	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—IFNG—ulcerative colitis	5.14e-06	0.00202	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—RELA—ulcerative colitis	5.07e-06	0.00199	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	4.95e-06	0.00194	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—PTGS2—ulcerative colitis	4.93e-06	0.00194	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	4.91e-06	0.00193	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	4.7e-06	0.00185	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	4.7e-06	0.00185	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—IL1B—ulcerative colitis	4.58e-06	0.0018	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	4.56e-06	0.00179	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—TNF—ulcerative colitis	4.52e-06	0.00178	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	4.38e-06	0.00172	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—IL2—ulcerative colitis	4.36e-06	0.00171	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—NFKB1—ulcerative colitis	4.28e-06	0.00168	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—TNF—ulcerative colitis	4.19e-06	0.00165	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—IL6—ulcerative colitis	4.15e-06	0.00163	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	4.12e-06	0.00162	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—GNA12—ulcerative colitis	4.11e-06	0.00161	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	4.09e-06	0.00161	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	4.06e-06	0.0016	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—ITGAL—ulcerative colitis	4.03e-06	0.00158	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—HNF4A—ulcerative colitis	3.99e-06	0.00157	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—MAML2—ulcerative colitis	3.89e-06	0.00153	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	3.85e-06	0.00151	CbGpPWpGaD
Enzalutamide—ALB—Platelet degranulation—TGFB1—ulcerative colitis	3.84e-06	0.00151	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—TP53—ulcerative colitis	3.69e-06	0.00145	CbGpPWpGaD
Enzalutamide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ulcerative colitis	3.66e-06	0.00144	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CHP1—ulcerative colitis	3.66e-06	0.00144	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—IL6—ulcerative colitis	3.65e-06	0.00143	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—PPARG—ulcerative colitis	3.6e-06	0.00141	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CHP1—ulcerative colitis	3.58e-06	0.00141	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	3.4e-06	0.00134	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	3.39e-06	0.00133	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—IL6—ulcerative colitis	3.38e-06	0.00133	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	3.34e-06	0.00131	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—TNF—ulcerative colitis	3.33e-06	0.00131	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—TNF—ulcerative colitis	3.18e-06	0.00125	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—DLD—ulcerative colitis	3.16e-06	0.00124	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CHP1—ulcerative colitis	3.1e-06	0.00122	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—DLD—ulcerative colitis	3.09e-06	0.00121	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CHP1—ulcerative colitis	3.08e-06	0.00121	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.93e-06	0.00115	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.9e-06	0.00114	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.89e-06	0.00114	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—CALM3—ulcerative colitis	2.86e-06	0.00112	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CHP1—ulcerative colitis	2.77e-06	0.00109	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CHP1—ulcerative colitis	2.7e-06	0.00106	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—IL6—ulcerative colitis	2.68e-06	0.00105	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—DLD—ulcerative colitis	2.68e-06	0.00105	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—DLD—ulcerative colitis	2.66e-06	0.00105	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.59e-06	0.00102	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CHP1—ulcerative colitis	2.54e-06	0.001	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CHP1—ulcerative colitis	2.52e-06	0.000992	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	2.51e-06	0.000985	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—VDR—ulcerative colitis	2.48e-06	0.000977	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—DLD—ulcerative colitis	2.39e-06	0.000939	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.36e-06	0.000929	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—DLD—ulcerative colitis	2.33e-06	0.000916	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.32e-06	0.000913	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—DLD—ulcerative colitis	2.2e-06	0.000863	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	2.19e-06	0.000859	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—DLD—ulcerative colitis	2.18e-06	0.000856	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	2.02e-06	0.000792	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.92e-06	0.000756	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—MMP1—ulcerative colitis	1.83e-06	0.000721	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.79e-06	0.000705	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—PPARG—ulcerative colitis	1.73e-06	0.000681	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	1.71e-06	0.00067	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.68e-06	0.00066	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.66e-06	0.000654	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.57e-06	0.000618	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.57e-06	0.000616	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTGS1—ulcerative colitis	1.53e-06	0.000601	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTGS1—ulcerative colitis	1.49e-06	0.000587	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—DLD—ulcerative colitis	1.44e-06	0.000564	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.41e-06	0.000556	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.41e-06	0.000553	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.38e-06	0.000543	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CALM3—ulcerative colitis	1.38e-06	0.000541	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CALM3—ulcerative colitis	1.34e-06	0.000528	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTGS1—ulcerative colitis	1.29e-06	0.000508	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—JAK2—ulcerative colitis	1.29e-06	0.000508	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTGS1—ulcerative colitis	1.29e-06	0.000506	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.27e-06	0.0005	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.26e-06	0.000496	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CALM3—ulcerative colitis	1.16e-06	0.000458	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CALM3—ulcerative colitis	1.16e-06	0.000455	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTGS1—ulcerative colitis	1.15e-06	0.000454	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.15e-06	0.000453	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.14e-06	0.000446	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.13e-06	0.000443	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—IL2—ulcerative colitis	1.13e-06	0.000443	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.11e-06	0.000437	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.11e-06	0.000435	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ABCB1—ulcerative colitis	1.07e-06	0.00042	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTGS1—ulcerative colitis	1.06e-06	0.000417	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.05e-06	0.000414	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTGS1—ulcerative colitis	1.05e-06	0.000414	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ABCB1—ulcerative colitis	1.05e-06	0.000411	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CALM3—ulcerative colitis	1.04e-06	0.000409	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.04e-06	0.000407	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CALM3—ulcerative colitis	1.01e-06	0.000399	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ADCY5—ulcerative colitis	9.98e-07	0.000392	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	9.94e-07	0.00039	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ADCY5—ulcerative colitis	9.76e-07	0.000383	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CALM3—ulcerative colitis	9.56e-07	0.000376	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CALM3—ulcerative colitis	9.48e-07	0.000373	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	9.06e-07	0.000356	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ABCB1—ulcerative colitis	9.06e-07	0.000356	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ABCB1—ulcerative colitis	9.01e-07	0.000354	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TGFB1—ulcerative colitis	8.79e-07	0.000345	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ADCY5—ulcerative colitis	8.45e-07	0.000332	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ADCY5—ulcerative colitis	8.4e-07	0.00033	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ABCB1—ulcerative colitis	8.08e-07	0.000318	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ADCY5—ulcerative colitis	7.54e-07	0.000296	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PPARG—ulcerative colitis	7.44e-07	0.000293	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ABCB1—ulcerative colitis	7.44e-07	0.000292	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ABCB1—ulcerative colitis	7.37e-07	0.00029	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ADCY5—ulcerative colitis	7.36e-07	0.000289	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PPARG—ulcerative colitis	7.28e-07	0.000286	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TP53—ulcerative colitis	7.24e-07	0.000284	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTGS1—ulcerative colitis	6.94e-07	0.000273	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ADCY5—ulcerative colitis	6.94e-07	0.000273	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ADCY5—ulcerative colitis	6.88e-07	0.00027	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ALB—ulcerative colitis	6.69e-07	0.000263	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ALB—ulcerative colitis	6.54e-07	0.000257	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PPARG—ulcerative colitis	6.3e-07	0.000248	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PPARG—ulcerative colitis	6.27e-07	0.000246	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CALM3—ulcerative colitis	6.25e-07	0.000246	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTGS2—ulcerative colitis	5.86e-07	0.00023	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTGS2—ulcerative colitis	5.72e-07	0.000225	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ALB—ulcerative colitis	5.67e-07	0.000223	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PPARG—ulcerative colitis	5.62e-07	0.000221	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PPARG—ulcerative colitis	5.49e-07	0.000216	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PPARG—ulcerative colitis	5.17e-07	0.000203	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PPARG—ulcerative colitis	5.13e-07	0.000202	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ALB—ulcerative colitis	5.06e-07	0.000199	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTGS2—ulcerative colitis	4.96e-07	0.000195	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ALB—ulcerative colitis	4.94e-07	0.000194	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTGS2—ulcerative colitis	4.93e-07	0.000194	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ABCB1—ulcerative colitis	4.86e-07	0.000191	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ALB—ulcerative colitis	4.65e-07	0.000183	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ALB—ulcerative colitis	4.61e-07	0.000181	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ADCY5—ulcerative colitis	4.54e-07	0.000178	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTGS2—ulcerative colitis	4.42e-07	0.000174	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTGS2—ulcerative colitis	4.32e-07	0.00017	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTGS2—ulcerative colitis	4.07e-07	0.00016	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTGS2—ulcerative colitis	4.03e-07	0.000159	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPARG—ulcerative colitis	3.38e-07	0.000133	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALB—ulcerative colitis	3.04e-07	0.00012	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTGS2—ulcerative colitis	2.66e-07	0.000105	CbGpPWpGaD
